AEGON's 2011 total EV increased 10% to EUR 20.7 billion
2012年5月10日 - 3:00PM
ＲＮＳを含む英国規制内ニュース （英語）
TIDMAGN
AEGON's 2011 total embedded value increased 10% to EUR 20.7 billion
* Embedded value life insurance declines 7% to EUR 23.9 billion as a result
of capital movements
* Total embedded value attributable to common shareholders increases 11% to
EUR 19.6 billion
* Total embedded value per common share remained level at EUR 10.42
AEGON's total embedded value at the end of 2011 totaled EUR 20.7 billion, an
increase of 10% compared with last year, as a lower embedded value life
insurance was more than offset by a higher book value for other activities and
lower market value of debt.
Embedded value for AEGON's life insurance businesses declined to EUR 23.9
billion mainly due to capital movements to the Group and other activities, and
the divestment of Transamerica Reinsurance. Operating margins on embedded value
increased to 8.6% in 2011 compared to 5.3% in 2010, driven by new business and
a positive performance from AEGON's existing in-force business.
The performance from AEGON's existing in-force business was driven by changes
in operating assumptions primarily related to lower future expenses related to
the restructuring program in the Netherlands and an update on mortality
assumptions on the universal life business in the Americas. This was partly
offset by the negative impact from restructuring and project costs and the
increase in the provision covering customer redress in the United Kingdom in
2011. The negative impact from economic assumption changes was mainly driven by
lower interest rates. This was partly offset by the positive impact of the
interest rate hedging program in the Netherlands. Embedded value also benefited
from favorable currency movements, in particular a strengthening of the US
dollar against the euro.
At the end of 2011, the free surplus on life insurance business declined to EUR
1.6 billion, due mainly to increased capital requirement in the US, and outflow
of capital to the Group and other activities. This was partly offset by
earnings on the in-force portfolio and the divestment of Transamerica
Reinsurance.
AEGON will discontinue publication of traditional embedded value metrics (EEV
and VNB). The press release covering the first quarter 2012 results no longer
includes traditional VNB, but contains market consistent value of new business
(MCVNB) information. AEGON will replace the full year traditional embedded
value report with information based on the new regulatory regime, Solvency II.
Embedded value Year-end Year-end
(amounts in millions unless stated otherwise, after tax) 2011 2010
EUR EUR %
Life business
Adjusted net worth (ANW) 15,702 15,959 (2)
Free surplus (FS) 1,628 3,261 (50)
Required surplus (RS) 14,074 12,697 11
Value of in-force life business (ViF) 8,243 9,798 (16)
Present value future profits (PVFP) 13,126 13,570 (3)
Cost of capital (CoC) (4,883) (3,772) (29)
Embedded value life insurance (EVLI) 23,945 25,756 (7)
Other activities
IFRS book value 2,264 733 209
Total embedded value before holding 26,208 26,489 (1)
activities
Holding activities (5,520) (7,598) 27
Market value of debt, capital securities
& other net liabilities (5,075) (7,098) 29
Present value holding expenses (446) (500) 11
Total embedded value (TEV) 20,688 18,891 10
Value of preferred share capital (1,104) (1,170) 6
Total embedded value (TEV) 19,585 17,721 11
attributable to common shareholders
TEV attributable to common shareholders 10.42 10.38 0
per share (EUR)
About AEGON
As an international life insurance, pensions and asset management company based
in The Hague, AEGON has businesses in over twenty markets in the Americas,
Europe and Asia. AEGON companies employ over 25,000 people and have nearly 47
million customers across the globe.
Key figures - EUR Q1 2012 Full year 2011
Underlying earnings 425 million 1.5 billion
before tax
New life sales 445 million 1.8 billion
Gross deposits 11.0 billion 32 billion
Revenue-generating
investments 437 billion 424 billion
(end of period)
Contact information
Media Relations:
Greg Tucker
+ 31 (0) 70 344 8956
gcc-ir@aegon.com
Investor Relations:
Willem van den Berg
+ 31 (0) 70 344 8305
ir@aegon.com
www.aegon.com
Cautionary note regarding non-GAAP measures
This document includes certain non-GAAP financial measures: underlying earnings
before tax and value of new business. The reconciliation of underlying earnings
before tax to the most comparable IFRS measure is provided in Note 3 "Segment
information" of AEGON's Condensed consolidated interim financial statements.
Value of new business is not based on IFRS, which are used to report AEGON's
primary financial statements and should not be viewed as a substitute for IFRS
financial measures. AEGON may define and calculate value of new business
differently than other companies. Please see AEGON's Embedded Value Report
dated May 10, 2012 for an explanation of how the company defines and calculates
value of new business. AEGON believes that these non-GAAP measures, together
with the IFRS information, provide a meaningful measure for the investment
community to evaluate AEGON's business relative to the businesses of its peers.
Local currencies and constant currency exchange rates
This document contains certain information about our results and financial
condition in USD for the Americas and GBP for the United Kingdom, because those
businesses operate and are managed primarily in those currencies. Certain
comparative information presented on a constant currency basis eliminates the
effects of changes in currency exchange rates. None of this information is a
substitute for or superior to financial information about us presented in EUR,
which is the currency of our primary financial statements.
Forward-looking statements
The statements contained in this document that are not historical facts are
forward-looking statements as defined in the US Private Securities Litigation
Reform Act of 1995. The following are words that identify such forward-looking
statements: aim, believe, estimate, target, intend, may, expect, anticipate,
predict, project, counting on, plan, continue, want, forecast, goal, should,
would, is confident, will, and similar expressions as they relate to AEGON.
These statements are not guarantees of future performance and involve risks,
uncertainties and assumptions that are difficult to predict. AEGON undertakes
no obligation to publicly update or revise any forward-looking statements.
Readers are cautioned not to place undue reliance on these forward-looking
statements, which merely reflect company expectations at the time of writing.
Actual results may differ materially from expectations conveyed in
forward-looking statements due to changes caused by various risks and
uncertainties. Such risks and uncertainties include but are not limited to the
following:
* Changes in general economic conditions, particularly in the United States,
the Netherlands and the United Kingdom;
* Changes in the performance of financial markets, including emerging
markets, such as with regard to:
- The frequency and severity of defaults by issuers in AEGON's fixed income
investment portfolios;
- The effects of corporate bankruptcies and/or accounting restatements on the
financial markets and the resulting decline in the value of equity and debt
securities AEGON holds; and
- The effects of declining creditworthiness of certain private sector
securities and the resulting decline in the value of sovereign exposure
that AEGON holds;
* Changes in the performance of AEGON's investment portfolio and decline in
ratings of the company's counterparties;
* Consequences of a potential (partial) break-up of the euro;
* The frequency and severity of insured loss events;
* Changes affecting mortality, morbidity, persistence and other factors that
may impact the profitability of AEGON's insurance products;
* Reinsurers to whom AEGON has ceded significant underwriting risks may fail
to meet their obligations;
* Changes affecting interest rate levels and continuing low or rapidly
changing interest rate levels; changes affecting currency exchange rates,
in particular the EUR/USD and EUR/GBP exchange rates;
* Changes in the availability of, and costs associated with, liquidity
sources such as bank and capital markets funding, as well as conditions in
the credit markets in general such as changes in borrower and counterparty
creditworthiness;
* Increasing levels of competition in the United States, the Netherlands, the
United Kingdom and emerging markets;
* Changes in laws and regulations, particularly those affecting AEGON's
operations, ability to hire and retain key personnel, the products the
company sells, and the attractiveness of certain products to its consumers;
* Regulatory changes relating to the insurance industry in the jurisdictions
in which AEGON operates;
* Acts of God, acts of terrorism, acts of war and pandemics;
* Changes in the policies of central banks and/or governments;
* Lowering of one or more of AEGON's debt ratings issued by recognized rating
organizations and the adverse impact such action may have on the company's
ability to raise capital and on its liquidity and financial condition;
* Lowering of one or more of insurer financial strength ratings of AEGON's
insurance subsidiaries and the adverse impact such action may have on the
premium writings, policy retention, profitability of its insurance
subsidiaries and liquidity;
* The effect of the European Union's Solvency II requirements and other
regulations in other jurisdictions affecting the capital AEGON is required
to maintain;
* Litigation or regulatory action that could require AEGON to pay significant
damages or change the way the company does business;
* As AEGON's operations support complex transactions and are highly dependent
on the proper functioning of information technology, a computer system
failure or security breach may disrupt the company's business, damage its
reputation and adversely affect its results of operations, financial
condition and cash flows;
* Customer responsiveness to both new products and distribution channels;
* Competitive, legal, regulatory, or tax changes that affect profitability,
the distribution cost of or demand for AEGON's products;
* Changes in accounting regulations and policies may affect AEGON's reported
results and shareholder's equity;
* The impact of acquisitions and divestitures, restructurings, product
withdrawals and other unusual items, including AEGON's ability to integrate
acquisitions and to obtain the anticipated results and synergies from
acquisitions;
* Catastrophic events, either manmade or by nature, could result in material
losses and significantly interrupt AEGON's business; and
* AEGON's failure to achieve anticipated levels of earnings or operational
efficiencies as well as other cost saving initiatives.
Further details of potential risks and uncertainties affecting the company are
described in the company's filings with NYSE Euronext Amsterdam and the US
Securities and Exchange Commission, including the Annual Report. These
forward-looking statements speak only as of the date of this document. Except
as required by any applicable law or regulation, the company expressly
disclaims any obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements contained herein to reflect any
change in the company's expectations with regard thereto or any change in
events, conditions or circumstances on which any such statement is based.
MAY 10, 2012
Press release
END
Aegon Nv (LSE:AGN)
過去 株価チャート
から 11 2024 まで 12 2024
Aegon Nv (LSE:AGN)
過去 株価チャート
から 12 2023 まで 12 2024
